1.
Evid. actual. práct. ambul
;
26(4): e007102, 2023.
Article
in Spanish
| LILACS, UNISALUD, BINACIS
| ID: biblio-1527141
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Coronary Artery Disease/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Rosuvastatin Calcium/administration & dosage , Atorvastatin/administration & dosage , Cholesterol, LDL/blood , Coronary Artery Disease/complications , Coronary Artery Disease/blood , Randomized Controlled Trials as Topic , Treatment Outcome , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Stroke/etiology , Rosuvastatin Calcium/adverse effects , Rosuvastatin Calcium/therapeutic use , Atorvastatin/adverse effects , Atorvastatin/therapeutic use , Myocardial Infarction/etiology
2.
Evid. actual. práct. ambul
;
19(4): 114-114, 2016. tab
Article
in Spanish
| LILACS
| ID: biblio-1150649